Skip to main content
Premium Trial:

Request an Annual Quote

Castle Biosciences Receives NYS DOH Approval for Skin Cancer Diagnostic

NEW YORK – Dermatologic diagnostics company Castle Biosciences said on Wednesday that it has received approval from the New York State Department of Health for its DecisionDx-SCC test.

Being a permitted laboratory in New York state allows patients there to access the company’s molecular diagnostic tests. Castle has previously received approvals in New York for its other genomic tests, DecisionDx-Melanoma, DecisionDx-UM, and DecisionDx-PRAME, as well as its next-generation sequencing panels, DecisionDx-CMSeq and DecisionDx-UMSeq.

The 40-gene expression profile DecisionDx-SCC test uses an individual patient's tumor biology to predict risk of cutaneous squamous cell carcinoma metastasis for patients with one or more risk factors. The test result stratifies patients into a Class 1, 2A, or 2B risk category, helping to inform risk-appropriate management, the company said.

Castle also noted that peer-reviewed publications have shown DecisionDx-SCC to be an independent predictor of metastatic risk, and that integrating the assay with current prognostic methods can add positive predictive value to clinician decisions regarding staging and management.

"As we continue to grow our suite of genomic tests addressing dermatologic conditions with high clinical need, each milestone is important in the advancement of patient care, including our recent accreditation for the DecisionDx-SCC test in the state of New York," Derek Maetzold, Castle's president and CEO, said in a statement.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.